3 reports

It develops product panels for diagnosing autoimmune diseases, allergies, and infectious diseases.

  • Clinical Trial
  • Immunohaematology
  • Monoclonal Antibody
  • United States
  • GlobalData's company

The Company will continue to maintain its core neurodegenerative disease assets for ALS and Alzheimer' s disease until one or more strategic transactions are consummated.

  • Immunohaematology
  • In Vitro Diagnostic Reagent
  • Canada
  • Company
  • Amorfix Life Sciences Ltd.

Initially, Myriad RBM will offer Simoa assay services for the study of inflammatory and autoimmune diseases.

  • Immunohaematology
  • Laboratory
  • North America
  • United States
  • BioTime, Inc.